March 31, 2026

The field of genetic and cellular medicines is advancing at an unprecedented pace, and there

Managing the lifecycle of Investigational Medicinal Products (IMP) requires more than just logistics; it demands

In the modern drug development world, the transition from clinical phases to commercial viability is